Fiona Sorrell - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Fiona Sorrell

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

ACS Medicinal Chemistry Letters|August 25, 2020

Mining Public Domain Data to Develop Selective DYRK1A InhibitorsScott H Henderson, Fiona Sorrell, James Bennett, et al.

Journal of Medicinal Chemistry|August 3, 2021

Discovery and Characterization of Selective and Ligand-Efficient DYRK InhibitorsScott H Henderson, Fiona Sorrell, James Bennett, et al.

Journal of Medicinal Chemistry|September 17, 2025

Fragment-Based Discovery and Structure-Led Optimization of MSC778, the First Potent, Selective, and Orally Bioavailable FEN1 InhibitorSam E Mann, Julien Lefranc, Omar Alkhatib, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

ACS Medicinal Chemistry Letters|August 25, 2020

Mining Public Domain Data to Develop Selective DYRK1A InhibitorsScott H Henderson, Fiona Sorrell, James Bennett, et al.

Journal of Medicinal Chemistry|August 3, 2021

Discovery and Characterization of Selective and Ligand-Efficient DYRK InhibitorsScott H Henderson, Fiona Sorrell, James Bennett, et al.

Journal of Medicinal Chemistry|September 17, 2025

Fragment-Based Discovery and Structure-Led Optimization of MSC778, the First Potent, Selective, and Orally Bioavailable FEN1 InhibitorSam E Mann, Julien Lefranc, Omar Alkhatib, et al.

Pageof 1